DAPAGLIFLOZIN for Hypertension: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 44 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN was used for Hypertension.
Most Reported Side Effects for DAPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,775 | 13.0% | 2,774 | 52 |
| Diabetic ketoacidosis | 1,773 | 8.3% | 61 | 1,154 |
| Acute kidney injury | 982 | 4.6% | 67 | 768 |
| Off label use | 891 | 4.2% | 28 | 310 |
| Nausea | 884 | 4.1% | 20 | 363 |
| Dehydration | 860 | 4.0% | 67 | 451 |
| Vomiting | 838 | 3.9% | 27 | 419 |
| Dizziness | 817 | 3.8% | 30 | 293 |
| Ketoacidosis | 803 | 3.8% | 30 | 471 |
| Fatigue | 785 | 3.7% | 8 | 227 |
| Diarrhoea | 769 | 3.6% | 32 | 317 |
| Dyspnoea | 760 | 3.6% | 21 | 328 |
| Malaise | 737 | 3.5% | 30 | 308 |
| Weight decreased | 727 | 3.4% | 23 | 231 |
| Blood glucose increased | 699 | 3.3% | 12 | 247 |
Other Indications for DAPAGLIFLOZIN
Type 2 diabetes mellitus (5,444)
Diabetes mellitus (3,347)
Product used for unknown indication (1,534)
Cardiac failure (1,332)
Chronic kidney disease (585)
Ill-defined disorder (556)
Cardiac failure chronic (498)
Type 1 diabetes mellitus (308)
Blood glucose increased (145)
Blood glucose abnormal (127)
Other Drugs Used for Hypertension
AMLODIPINE (20,207)
LISINOPRIL (11,824)
RAMIPRIL (10,210)
VALSARTAN (8,956)
LOSARTAN (7,966)
FUROSEMIDE (7,490)
HYDROCHLOROTHIAZIDE (7,119)
METOPROLOL (5,918)
OLMESARTAN MEDOXOMIL (5,702)
BISOPROLOL (5,520)